case_images: PMC6232809_01
case_images: Ultrasonography of the thyroid. (a) Heterogeneous and hypoechoic areas were observed in both thyroid lobes before treatment. (b) Hypervascularity and a reduction in hypoechoic areas, indicating improvement, were observed 10 weeks after treatment initiation.
case_images: CRIE2018-3210317.001.jpg
case_images: PMC6232809_01_CRIE2018-3210317.001.jpg
case_images: fig1
case_images: Ultrasonography (US) of the thyroid revealed heterogeneous and hypoechoic areas, which are features of subacute thyroiditis, in both thyroid lobes (Figure 1).
case_images: Changes in serum thyroid levels during the clinical course. 5*, 5 mg every 2 days; PSL, prednisolone; MMI, methimazole; PTU, propylthiouracil; T3, triiodothyronine; T4, thyroxine.
case_images: CRIE2018-3210317.002.jpg
case_images: PMC6232809_01_CRIE2018-3210317.002.jpg
case_images: fig2
case_images: The PSL dose was gradually tapered, and thyroid hormone levels decreased, although they were still above normal 6 weeks after treatment start (Figure 2).